IP Library Assignment 066276/0577
Patent Assignment
Reel/Frame 066276/0577

Assignment of Assignor's Interest

Recorded: 2024-01-29 Pages: 10
Assignor
ACTELION PHARMACEUTICALS LTD
Executed: 2023-12-07
Assignee
VANDA PHARMACEUTICALS INC.
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DISTRICT OF COLUMBIA, 20037
Covered Properties (33)
Dosing Regimen for a Selective S1P1 Receptor Agonist
Application: 18/046,492 →
Publication: US US20230131600A1
Pharmaceutical Combination Comprising a Selective S1P1 Receptor Agonist
Application: 18/315,954 →
Publication: US US20240139160A1
Pharmaceutical Combination Comprising Ponesimod
Application: 18/341,853 →
Publication: US US20240139161A1
Ponesimod for Avoiding Worsening of Fatigue -Related Symptoms in Multiple Sclerosis Patients
Application: 17/628,387 →
Publication: US US20220273623A1
Methods of Slowing Brain Volume Loss
Application: 17/908,684 →
Publication: US US20230123588A1
Pharmaceutical Dosage System
Application: 17/697,007 →
Publication: US US20220296468A1
Methods Of Treating Multiple Sclerosis
Application: 17/962,968 →
Publication: US US20230143217A1
Methods Of Treating Multiple Sclerosis
Application: 17/962,714 →
Publication: US US20230114486A1
Methods Of Treating Multiple Sclerosis
Application: 17/962,679 →
Publication: US US20230144895A1
Methods Of Treating Multiple Sclerosis
Application: 17/962,641 →
Publication: US US20230113378A1
Methods of Treating Multiple Sclerosis
Application: 63/336,166 →
Methods Of Treating Multiple Sclerosis
Application: 63/342,803 →
Methods of Slowing an Increase in Brain Ventricular Volume
Application: 63/309,250 →
Methods for Treating Multiple Sclerosis
Application: 18/565,690 →
Publication: US US20240261267A1
Methods of Slowing an Increase in Brain Ventricular Volume
Application: 18/565,752 →
Publication: US US20240261268A1
Novel Thiazolidin-4-One-Derivatives
Patent: 9,000,018 →
Application: 13/951,954 →
Publication: US US20130310432A1
Novel Thiazolidin 4-One Derivatives
Patent: 8,273,779 →
Application: 12/496,945 →
Publication: US US20090275625A1
Novel Thiazolidin-4-One Derivatives
Patent: 8,524,752 →
Application: 13/570,956 →
Publication: US US20120302612A1
Thiazolidin-4-One Derivatives
Patent: 43,728 →
Application: 13/194,172 →
Thiazolidin-4-One Derivatives
Patent: 43,833 →
Application: 13/205,768 →
Thiazolidin-4-One Derivatives
Patent: 45,174 →
Application: 14/028,712 →
New Process for the Preparation of 2-Imino-Thiazolidin-4-One Derivatives
Patent: 8,912,340 →
Application: 13/565,469 →
Publication: US US20120302758A1
New Process for the Preparation of 2-Imino-Thiazolidin-4-One Derivatives
Patent: 8,263,780 →
Application: 12/516,055 →
Publication: US US20110201821A2
Crystalline Forms of (R) -5-[3-Chloro-4-(2,3-Dihydroxy-Propoxy)-Benz [Z] Ylidene] -2-( [Z]-Propylimino) -3-0-Tolyl-Thiazolidin-4-One
Patent: 9,062,014 →
Application: 13/125,102 →
Publication: US US20110196004A1
Process for the Preparation of [(2Z,5Z)-5-(3-Chloro-4-((R)-2,3-Dihydroxypropoxy)Benzylidene)-2-(Propylimino)-3-](O-Tolyl)Thiazolidin-4-One and Intermediate Used in Said Process
Patent: 9,340,518 →
Application: 14/422,167 →
Publication: US US20150203459A1
Dosing Regimen for a Selective S1P1 Receptor Agonist
Application: 16/261,327 →
Publication: US US20190151292A1
Dosing Regimen for a Selective S1P1 Receptor Agonist
Application: 17/090,756 →
Publication: US US20210052555A1
Dosing Regimen for a Selective S1P1 Receptor Agonist
Application: 15/534,929 →
Publication: US US20180147188A9
Pharmaceutical Combination Comprising a Selective S1P1 Receptor Agonist
Application: 17/325,912 →
Publication: US US20210338640A1
Pharmaceutical Combination Comprising a Selective S1P1 Receptor Agonist
Application: 16/277,829 →
Publication: US US20190175563A1
Pharmaceutical Combination Comprising a Selective S1P1 Receptor Agonist
Application: 15/534,951 →
Publication: US US20170348287A1
Pharmaceutical Combination Comprising Ponesimod
Application: 16/494,163 →
Publication: US US20200069655A1
Pharmaceutical Package
Patent: 974,921 →
Application: 29/775,260 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 29, 2012
From: BINKERT, CHRISTOPH; BOLLI, MARTIN; MATHYS, BORIS; MUELLER, CLAUS
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 028866/0590 →
Assignment of Assignor's Interest Oct 5, 2012
From: BINKERT, CHRISTOPH; BOLLI, MARTIN; MATHYS, BORIS; MUELLER, CLAUS
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 029084/0524 →
Assignment of Assignor's Interest Feb 18, 2014
From: ABELE, STEFAN; BOLLI, MARTIN; SCHMIDT, GUNTHER
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 032237/0339 →
Assignment of Assignor's Interest Jan 19, 2022
From: BURCKLEN, MICHEL; HENNESSY, BRIAN; VACLAVKOVA, ANDREA
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 058695/0740 →
Assignment of Assignor's Interest Jan 19, 2022
From: JANSSEN RESEARCH & DEVELOPMENT, LLC
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 058695/0885 →
Assignment of Assignor's Interest Jan 19, 2022
From: EL AKKAD, TAREK; KEENAN, ALEXANDER
To: JANSSEN RESEARCH & DEVELOPMENT, LLC
Reel/Frame 058695/0825 →
Assignment of Assignor's Interest Oct 4, 2022
From: SPILLER, KRISTA; BHATTACHARYA, ANINDYA; WONG, JANICE
To: JANSSEN RESEARCH & DEVELOPMENT, LLC
Reel/Frame 061300/0007 →
Assignment of Assignor's Interest Oct 4, 2022
From: SIDORENKO, TATIANA
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 061300/0183 →
Assignment of Assignor's Interest Oct 4, 2022
From: JANSSEN RESEARCH & DEVELOPMENT, LLC
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 061301/0606 →
Assignment of Assignor's Interest Oct 4, 2022
From: SPILLER, KRISTA; BHATTACHARYA, ANINDYA; WONG, JANICE
To: JANSSEN RESEARCH & DEVELOPMENT, LLC
Reel/Frame 061309/0734 →
Assignment of Assignor's Interest Oct 4, 2022
From: SIDORENKO, TATIANA
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 061309/0769 →
Assignment of Assignor's Interest Oct 4, 2022
From: JANSSEN RESEARCH & DEVELOPMENT, LLC
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 061309/0806 →
Assignment of Assignor's Interest Nov 30, 2022
From: BURCKLEN, MICHEL; HENNESSY, BRIAN PATRICK; KRACKER, HILKE; LINSCHEID, PHILIPPE
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 061917/0741 →
Assignment of Assignor's Interest Dec 12, 2022
From: AIT-TIHYATY, MARIA
To: JANSSEN INC.
Reel/Frame 062052/0398 →
Assignment of Assignor's Interest Dec 12, 2022
From: SAAD, ZIAD SERHAL; DATTA, RITOBRATO; KOLB, HARTMUTH
To: JANSSEN RESEARCH & DEVELOPMENT, LLC
Reel/Frame 062053/0858 →
Assignment of Assignor's Interest Dec 12, 2022
From: JANSSEN INC.
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 062054/0613 →
Assignment of Assignor's Interest Dec 12, 2022
From: DIBERNARDO, ALLITIA; WIEGAND, FRANK, DR.
To: JANSSEN GLOBAL SERVICES, LLC
Reel/Frame 062054/0470 →
Assignment of Assignor's Interest Dec 12, 2022
From: JANSSEN GLOBAL SERVICES, LLC
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 062054/0986 →
Assignment of Assignor's Interest Dec 12, 2022
From: JANSSEN RESEARCH & DEVELOPMENT, LLC
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 062054/0771 →
Assignment of Assignor's Interest Dec 14, 2022
From: JANSSEN INC.
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 062085/0984 →
Assignment of Assignor's Interest Dec 14, 2022
From: AIT-TIHYATY, MARIA
To: JANSSEN INC.
Reel/Frame 062085/0897 →
Assignment of Assignor's Interest Dec 22, 2022
From: AIT-TIHYATY, MARIA
To: JANSSEN INC.
Reel/Frame 062181/0694 →
Assignment of Assignor's Interest Dec 22, 2022
From: JANSSEN INC.
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 062181/0862 →
Assignment of Assignor's Interest Dec 22, 2022
From: JANSSEN GLOBAL SERVICES, LLC
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 062181/0964 →
Assignment of Assignor's Interest Dec 22, 2022
From: DIBERNARDO, ALLITIA
To: JANSSEN GLOBAL SERVICES, LLC
Reel/Frame 062181/0619 →